Scenarios that move DGX
Quest Diagnostics Incorporated Common Stock
Scenarios that move DGX: 6 analyses, 4 positive, 2 negative.
- · OPKO Health to sell BioReference assets to Labcorp for $722M — ▼ · impact -45 · confidence high · horizon quarters
- · UnitedHealth tops estimates, raises profit outlook despite high medical costs — ▲ · impact +36 · confidence low · horizon quarters
- · argenx meets primary endpoint in Phase II celiac disease study — ▲ · impact +12 · confidence low · horizon quarters
- · DBV Technologies files FDA BLA for VIASKIN Peanut patch — ▲ · impact +12 · confidence low · horizon quarters
- · Mirum's Brelovitug meets goal in Phase III AZURE-1 study — ▲ · impact +18 · confidence low · horizon quarters
- · Amgen shares fall after Novartis' Pelacarsen misses Phase III goal — ▼ · impact -15 · confidence low · horizon quarters